Signet Financial Management, LLC Abb Vie Inc. Transaction History

Signet Financial Management, LLC

$778 Million
Q3 2024

A detailed history of Signet Financial Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Signet Financial Management, LLC holds 42,247 shares of ABBV stock, worth $7.17 Million. This represents 1.07% of its overall portfolio holdings.

Number of Shares

42,247

Previous 42,541 0.69%

Holding current value

$7.17 Million

Previous $7.3 Million 14.34%

% of portfolio

1.07%

Previous 0.99%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$163.84 - $199.33 $48,168 - $58,603	-294 Reduced 0.69%	42,247 $8.34 Million
Q2 2024 Aug 02, 2024	SELL	$154.79 - $180.76 $19,039 - $22,233	-123 Reduced 0.29%	42,541 $7.3 Million
Q1 2024 Apr 15, 2024	BUY	$159.82 - $182.1 $20,456 - $23,308	128 Added 0.3%	42,664 $7.77 Million
Q4 2023 Jan 30, 2024	SELL	$137.6 - $154.97 $17,888 - $20,146	-130 Reduced 0.3%	42,536 $6.59 Million
Q3 2023 Oct 25, 2023	SELL	$133.59 - $154.65 $242,733 - $280,999	-1,817 Reduced 4.08%	42,666 $6.36 Million
Q2 2023 Jul 18, 2023	SELL	$132.51 - $164.9 $137,545 - $171,166	-1,038 Reduced 2.28%	44,483 $5.99 Million
Q1 2023 Apr 17, 2023	SELL	$144.61 - $166.54 $33,694 - $38,803	-233 Reduced 0.51%	45,521 $7.25 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $42,461 - $50,922	-307 Reduced 0.67%	45,754 $7.4 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $34,089 - $39,098	254 Added 0.55%	46,061 $6.18 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $4,128 - $5,248	30 Added 0.07%	45,807 $7.02 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $24,944 - $30,948	-189 Reduced 0.41%	45,777 $7.42 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $32,121 - $40,643	299 Added 0.65%	45,966 $6.22 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $4,681 - $5,314	-44 Reduced 0.1%	45,667 $4.93 Million
Q2 2021 Aug 09, 2021	SELL	$105.21 - $117.21 $16,623 - $18,519	-158 Reduced 0.34%	45,711 $5.15 Million
Q1 2021 May 05, 2021	SELL	$102.3 - $112.62 $146,186 - $160,933	-1,429 Reduced 3.02%	45,869 $4.96 Million
Q4 2020 Feb 10, 2021	SELL	$80.49 - $108.67 $84,594 - $114,212	-1,051 Reduced 2.17%	47,298 $5.07 Million
Q3 2020 Nov 05, 2020	SELL	$85.91 - $100.83 $264,860 - $310,858	-3,083 Reduced 5.99%	48,349 $4.57 Million
Q2 2020 Aug 18, 2020	SELL	$73.37 - $98.18 $973,179 - $1.3 Million	-13,264 Reduced 20.5%	51,432 $4.75 Million
Q1 2020 May 20, 2020	SELL	$64.5 - $97.79 $374,100 - $567,182	-5,800 Reduced 8.23%	64,696 $5.85 Million
Q4 2019 Jan 23, 2020	SELL	$72.13 - $90.25 $96,654 - $120,935	-1,340 Reduced 1.87%	70,496 $6.24 Million
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $172,250 - $207,094	-2,735 Reduced 3.67%	71,836 $6.15 Million
Q2 2019 Aug 13, 2019	SELL	$65.7 - $83.98 $413,187 - $528,150	-6,289 Reduced 7.78%	74,571 $5.05 Million
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $529,257 - $622,910	-6,861 Reduced 7.82%	80,860 $6.35 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $288,901 - $356,293	-3,711 Reduced 4.06%	87,721 $8.09 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $373,866 - $415,622	-4,205 Reduced 4.4%	91,432 $8.65 Million
Q2 2018 Aug 10, 2018	SELL	$89.78 - $106.23 $90,139 - $106,654	-1,004 Reduced 1.04%	95,637 $8.86 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $64,591 - $86,493	702 Added 0.73%	96,641 $9.15 Million
Q4 2017 Feb 13, 2018	SELL	$89.56 - $98.21 $125,473 - $137,592	-1,401 Reduced 1.44%	95,939 $9.28 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $6.8 Million - $8.68 Million	97,340	97,340 $8.65 Million

Others Institutions Holding ABBV

# of Institutions

3,837

Shares Held

1.25B

Call Options Held

15.7M

Put Options Held

11.3M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $300B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signet Financial Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signet Financial Management, LLC with notifications on news.

Account

Signet Financial Management, LLC Abb Vie Inc. Transaction History